On November 19, 2024, the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) extended temporary rules that allow for virtual medication-assisted addiction treatment and prescriptions of controlled substances. The extension will run from January 1 through December 31, 2025. People with opioid use disorder currently receiving or entering addiction treatment will be able to receive prescriptions for buprenorphine without the need for an in-person visit.

Without the temporary rule extension, federal regulations would revert to those established by the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (Ryan Haight Act) which permits . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.